| Financial Year |
March 31 2023 |
| Monetary Funds |
1,905,275,830.95 |
| Held-for-trading Financial Assets |
105,516,407.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
801,997,805.30 |
| Advances to Suppliers |
27,575,892.98 |
| Other Receivables |
43,686,266.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
672,571,009.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
150,725,595.67 |
| Other Current Assets |
25,182,373.02 |
| Total Current Assets |
3,973,793,757.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
95,441,309.33 |
| Investment Properties |
7,937,240.08 |
| Fixed Assetes |
881,763,952.14 |
| Under-construction Projects |
63,318,376.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
286,411,197.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,161,401.01 |
| Deferred Income Tax Assets |
97,207,410.62 |
| Other Non-Current Assets |
68,325,478.06 |
| Sub-Total of Non-Current Assets |
3,068,229,757.99 |
| Total Assets |
7,042,023,515.86 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
615,831,505.34 |
| Accounts Payable |
755,480,528.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,663,682.82 |
| Taxes Payable |
63,673,248.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
197,693,495.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
452,093.82 |
| Other Current Liabilities |
393,321,723.78 |
| Sub-Total of Current Liabilities |
2,356,905,679.83 |
| Long-term Loans |
169,637,993.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,984,325.57 |
| Deferred Income Tax Liabilities |
12,731,760.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
244,600,767.53 |
| Total Liabilities |
2,601,506,447.36 |
| Paid-In Capital(Or Share Stock) |
743,600,000.00 |
| Capital Surplus |
904,125,065.75 |
| Surplus Reserve |
350,980,547.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,587,072,806.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,440,517,068.50 |
| Owner's Equity（Stockholder's Equity） |
4,440,517,068.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,042,023,515.86 |
